The formation of advanced glycation end products (AGEs) is a result of the non-enzymatic
reaction between sugars and free amino groups of proteins. AGEs, through interacting with …

The formation of advanced glycation endproducts (AGEs) occurs in diverse settings such as
diabetes, aging, renal failure, inflammation and hypoxia. The chief cellular receptor for …

The surface receptor for advanced glycosylation end-products (RAGE) and its soluble
(sRAGE) and endogenous secretory (EN-RAGE) forms belong to the superfamily of toll-like …

Objective—Advanced glycation end products play a pivotal role in atherosclerosis. Recently,
we showed that tissue advanced glycation end products deposition, noninvasively assessed …

Advanced glycation end products (AGEs) are a series of stable compounds produced under
non-enzymatic conditions by the amino groups of biomacromolecules and the free carbonyl …

Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disorder that is
clinically complex and has increased production of autoantibodies. Via emerging …

Advanced glycation end products (AGEs) are a family of compounds of diverse chemical
nature that are the products of nonenzymatic reactions between reducing sugars and …

The interaction of reactive oxygen species (ROS) with lipids, proteins, nucleic acids and
hydrocarbonates promotes acute and chronic tissue damage, mediates immunomodulation …

Systemic lupus erythematosus (SLE) is characterized by abnormal action of the immune
system and a state of chronic inflammation. The disease can cause life-threatening …

Advanced glycation end products (AGEs) are a class of compounds formed by
nonenzymatic interactions between reducing sugars and proteins, lipids, or nucleic acids …